Quoin Pharmaceuticals Ltd Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IKARIAN CAPITAL, LLC | 05/15/2026 | 211.54 K | $1.40 M | 0.00% | 10.79% |
| DAUNTLESS INVESTMENT GROUP, LLC | 05/14/2026 | 196.59 K | $1.30 M | 100.00% | 10.02% |
| SUMMITTX CAPITAL, L.P. | 05/15/2026 | 100.30 K | $661.98 K | 54.80% | 5.11% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 05/15/2026 | 84.85 K | $560.00 K | 100.00% | 4.33% |
| WOODLINE PARTNERS LP | 05/15/2026 | 79.58 K | $525.24 K | 0.00% | 4.06% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 76.25 K | $503.23 K | 1.91% | 3.89% |
| ABRDN PLC | 04/29/2026 | 75.00 K | $495.00 K | 0.00% | 3.82% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 05/14/2026 | 72.73 K | $480.02 K | 190.92% | 3.71% |
| CENTIVA CAPITAL, LP | 05/14/2026 | 60.00 K | $396.00 K | 397.80% | 3.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2026 | 59.84 K | $394.93 K | 0.00% | 3.05% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 05/14/2026 | 53.46 K | $352.84 K | -31.63% | 2.73% |
| AIGH CAPITAL MANAGEMENT LLC | 04/30/2026 | 51.00 K | $336.60 K | 3.40% | 2.60% |
| CITADEL ADVISORS LLC | 05/15/2026 | 32.52 K | $214.63 K | 100.00% | 1.66% |
| BIRCHVIEW CAPITAL, LP | 05/15/2026 | 20.00 K | $132.00 K | 100.00% | 1.02% |
| MORGAN STANLEY | 05/15/2026 | 4.00 K | $26.40 K | 33.33% | 0.20% |
| UBS GROUP AG | 05/05/2026 | 2.51 K | $16.58 K | 14,676.47% | 0.13% |
| GAMMA INVESTING LLC | 04/06/2026 | 1.72 K | $11.35 K | -17.47% | 0.09% |
| RHUMBLINE ADVISERS | 05/12/2026 | 1.52 K | $10.03 K | -8.70% | 0.08% |
| BARCLAYS PLC | 05/15/2026 | 1.30 K | $8.58 K | 100.00% | 0.07% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 2 | $13 | -99.19% | 0.00% |
| RESOLUTE CAPITAL ASSET PARTNERS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SIMPLIFY ASSET MANAGEMENT INC. | 04/27/2026 | 0 | $0 | -100.00% | 0.00% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
Quoin Pharmaceuticals Ltd institutional Ownership - FAQ's
During the previous two years, 24 institutional investors and hedge funds held shares of Quoin Pharmaceuticals Ltd. The most heavily invested institutionals were:
Ikarian Capital, LLC: 211,538
Dauntless Investment Group, LLC: 196,592
SummitTX Capital, L.P.: 100,300
Velan Capital Investment Management LP: 84,849
Woodline Partners LP: 79,582
MILLENNIUM MANAGEMENT LLC: 76,247
60.41% of Quoin Pharmaceuticals Ltd stock is owned by institutional investors.
Institutional investors have bought a total of 1.21 M shares in the last 24 months. This purchase volume represents approximately $10.20 M in transactions.